Study on the Anti-angiogenic Activity of Ethanol Extract of Bojungbangam-tang

보정방암탕 에타놀층의 혈관형성 저해작용에 관한 연구

  • Lee Eun-Ok (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University) ;
  • Shim Beom-Sang (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University) ;
  • Surh Young-Joon (College of Pharmacy, Seoul National University) ;
  • Jeon Byung-Hun (Department of Oriental Pathology, College of Oriental Medicine, Wonkwang University) ;
  • Ahn Kyoo-Seok (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University) ;
  • Kim Sung-Hoon (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University)
  • 이은옥 (경희대학교 한의과대학 병리학교실) ;
  • 심범상 (경희대학교 한의과대학 병리학교실) ;
  • 서영준 (서울대학교 약학대학 생화학교실) ;
  • 전병훈 (원광대학교 한의과대학 병리학교실) ;
  • 안규석 (경희대학교 한의과대학 병리학교실) ;
  • 김성훈 (경희대학교 한의과대학 병리학교실)
  • Published : 2006.02.01


The anti-angiogenic activity of ethanol extract of Bojungbangam-tang, a new herbal prescription composed of nine crude drugs, was evaluated in human umbilical vein endothelial cells (HUVECs). HPLC profile revealed that five major compunds such as apioliquiritin, narirutin, hesperidin, liquiritin and glycyrrhizin. Ethanol extract of Bojungbangam-tang (EBJT) did not showed any significant cytotoxicity against HUVECs up to 200 ug/ml. EBJT significantly inhibited basic fibroblast growth factor (bFGF)-induced HUVECs proliferation to 69% at 200 ${\mu}g/ml$. Migration using window scraping method and tube formation in bFGF stimulated HUVECs were also significantly suppressed by EBJT in a dose-dependent manner. Taken together, these results suggest that Bojungbangam-tang can be a potent prescription for angiogenesis related disease.


  1. Griffioen, A.W., Molema, G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52(2):237-268, 2000
  2. Bergers, G., Benjamin, L. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 3, 401-410, 2002
  3. Folkman, J. Angiogenesis and apoptosis. Semin. Cancer Biol. 13, 159-167, 2003
  4. Carmeliet, P., Jain, R.K. Angiogenesis in cancer and other diseases. Nature. 407, 249-257, 2000
  5. Folkman, J., Siegel, Y. Angiogenesis. J Biol Chem. 267, 10931-10934, 1992
  6. Boyd, D. Invasion and metastasis. Cancer Metastasis Rev. 15(1):77-89, 1996
  7. Plate, K.H., Breier, G., Risau, W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol. 4, 207-218, 1994
  8. Huh, J.E., Lee, E.O., Kim, M.S., Kang, K.S., Kim, C.H., Cha, B.C., Surh, Y.J., Kim, S.H. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis. 26(8):1436-1445, 2005
  9. Lee, J.H., Shim, B.S., Ahn, K.S., Choi, S.H. Anti-metastatic effects of Xuefuzhuyutang. J Korean Oriental Oncology. 5, 61-75, 1999
  10. Kang, D.I., Kim, S.H., Shim, B.S., Choi, S.H., Ahn, K.S. Study on the angiogenic inhibition effects of Molyaksan. Korean J. Oriental Medical Pathology. 14, 91-107, 2000
  11. Sohn, J.G., Kim, S.H., Seok, D.S., SHim, B.S., Choi, S.H., Ahn, K.S. Effect of Huoluoxiaolindan on anti-metastasis. Korean J. Oriental Medical Pathology. 14, 182-198, 2000
  12. Choi, H., Park, J.H., Yu, Y.B., Shim, B.S., Choi, S.H., Ahn, K.S. Anti-angiogenic effects of Sipjeondaebo-tang. Korean J Oriental Physiology & Pathology. 15 , 403-411, 2001
  13. Lee, J.W., Kim, H.Y., Kang, H., Yu, Y.B., Shim, B.S., Choi, S.H., Ahn, K.S. Angiogenic inhibition effects of several herbs supplementing Qi and blood. Korean J Oriental Physiology & Pathology. 16, 499-506, 2002
  14. Lee, H.J., Lee, E.O., Oh, S.S., Ahn, K.S., Park, Y.D., Kim, S.H. Study on the anti-angiogenic activity of KMKKTE. Korean J Oriental Physiology & Pathology. 18, 990-994, 2004
  15. Lee, S.J., Saiki, I., Hayakawa, Y., Nunome, S., Yamada, H., Kim, S.H. Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangam-tang. Int. Immunopharmacol. 3(2):147-157, 2003
  16. Jaffe, E.A., Nachman, R.L., Becker, C.G., Minick, C.R. Culture of human endothelial cells derived from umbilical veins.Identification by morphologic and immunologic criteria. J Clin Invest. 52, 2745-2756, 1973
  17. Jost, L.M., Kirkwood, J.M., Whiteside, T.L. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods. 147, 153-165, 1992
  18. Reynolds, A.R., Reynolds, L.E., Nagel, T.E., Lively, J.C., Robinson, S.D., Hicklin, D.J., Bodary, S.C., Hodivala-Dilke, K.M. Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in $\beta3$-Integrin-Deficient Mice. Cancer Res. 64, 8643-8650, 2004
  19. Grant, D.S., Kinsella, J.L., Fridman, R., Auerbach, R., Piasecki, B.A., Yamada, Y., Zain, M., Kleinman, H.K. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol. 153, 614-625, 1992
  20. Hasan, J., Shnyder, S.D., Clamp, A.R., McGown, A.T., Bicknell, R., Presta, M., Bibby, M., Double, J., Craig, S., Leeming, D., Stevenson, K., Gallagher, J.T., Jayson, G.C. Heparin octasaccharides inhibit angiogenesis in vivo. Clin. Cancer Res. 11(22):8172-8179, 2005